Publicado 01/12/2022 13:32
- Comunicado -

Nordic Nanovector ASA: Extraordinary General Meeting held

(Información remitida por la empresa firmante)

OSLO, Norway, Dec. 1, 2022 /PRNewswire/ -- An Extraordinary General Meeting (the "EGM") of Nordic Nanovector ASA (the "Company") (OSE: NANOV) was held today on 1 December 2022 in Oslo, Norway.

The matters under item 3, the proposed transaction with APIM Therapeutics AS, did not obtain sufficient majority of votes and was thus voted down. Due to the results under item 3, the EGM did not vote for the matters under item 4, 5, 6 and 7. The complete minutes of the EGM are attached to this release, and are available on www.nordicnanovector.com.

For further information, please contact:

IR enquiriesMalene Brondberg, interim CEO and CFOCell: +44 7561 431 762Email: ir@nordicnanovector.com

Media EnquiriesMark Swallow/Frazer Hall (MEDiSTRAVA Consulting)Tel: +44 203 928 6900Email: nordicnanovector@medistrava.com

This information is subject to a duty of disclosure pursuant to Section 5-12 of the Securities Trading Act.

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/nordic-nanovector-asa-extraordinary-general-meeting-held-301691397.html

Contenido patrocinado